111 related articles for article (PubMed ID: 11133219)
1. Manipulating the contractile apparatus: genetically defined animal models of cardiovascular disease.
Dalloz F; Osinska H; Robbins J
J Mol Cell Cardiol; 2001 Jan; 33(1):9-25. PubMed ID: 11133219
[TBL] [Abstract][Full Text] [Related]
2. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
Ramírez CD; Padrón R
Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
[TBL] [Abstract][Full Text] [Related]
3. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
Redwood CS; Moolman-Smook JC; Watkins H
Cardiovasc Res; 1999 Oct; 44(1):20-36. PubMed ID: 10615387
[TBL] [Abstract][Full Text] [Related]
4. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
Sorajja P; Elliott PM; McKenna WJ
Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
[No Abstract] [Full Text] [Related]
5. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of familial hypertrophic cardiomyopathy (FHC).
Bashyam MD; Savithri GR; Kumar MS; Narasimhan C; Nallari P
J Hum Genet; 2003; 48(2):55-64. PubMed ID: 12601548
[TBL] [Abstract][Full Text] [Related]
7. [Genetically modified animal models in cardiovascular research].
Dalloz F; Osinska H; Robbins J
Rev Esp Cardiol; 2001 Jun; 54(6):764-89. PubMed ID: 11412782
[TBL] [Abstract][Full Text] [Related]
8. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
[TBL] [Abstract][Full Text] [Related]
9. Remodeling the cardiac sarcomere using transgenesis.
Robbins J
Annu Rev Physiol; 2000; 62():261-87. PubMed ID: 10845092
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA
Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629
[TBL] [Abstract][Full Text] [Related]
11. Cardiac myosin binding protein C: its role in physiology and disease.
Flashman E; Redwood C; Moolman-Smook J; Watkins H
Circ Res; 2004 May; 94(10):1279-89. PubMed ID: 15166115
[TBL] [Abstract][Full Text] [Related]
12. [Hypertrophic cardiomyopathy].
Arbustini E; Dal Bello B
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):213-23. PubMed ID: 12497910
[No Abstract] [Full Text] [Related]
13. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.
Tardiff JC
Heart Fail Rev; 2005 Sep; 10(3):237-48. PubMed ID: 16416046
[TBL] [Abstract][Full Text] [Related]
14. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.
Semsarian C; Healey MJ; Fatkin D; Giewat M; Duffy C; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2001 Nov; 33(11):2055-60. PubMed ID: 11708849
[TBL] [Abstract][Full Text] [Related]
15. Childhood spinal muscular atrophy induces alterations in contractile and regulatory protein isoform expressions.
Stevens L; Bastide B; Maurage CA; Dupont E; Montel V; Cieniewski-Bernard C; Cuisset JM; Vallée L; Mounier Y
Neuropathol Appl Neurobiol; 2008 Dec; 34(6):659-70. PubMed ID: 18363640
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains.
Yang Q; Osinska H; Klevitsky R; Robbins J
J Mol Cell Cardiol; 2001 Sep; 33(9):1649-58. PubMed ID: 11549344
[TBL] [Abstract][Full Text] [Related]
17. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
[TBL] [Abstract][Full Text] [Related]
18. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R
Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of hypertrophic cardiomyopathy.
Morita H; DePalma SR; Arad M; McDonough B; Barr S; Duffy C; Maron BJ; Seidman CE; Seidman JG
Cold Spring Harb Symp Quant Biol; 2002; 67():383-8. PubMed ID: 12858563
[No Abstract] [Full Text] [Related]
20. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
